Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 24 pp 25767—25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Figure 7. Anti-tumor activity of ZnO-NPs in vivo. (A) image of subcutaneous xenograft tumors.(B) Tumor weight. * P< 0.05 vs. Control.